The historical rank and industry rank for Arcus Biosciences's FCF Margin % or its related term are showing as below:
RCUS'
s FCF Margin % Range Over the Past 10 Years
Min: -2163.69 Med: -282.05 Max: 380.36
Current: -99.16
During the past 8 years, the highest FCF Margin % of Arcus Biosciences was 380.36%. The lowest was -2163.69%. And the median was -282.05%.
RCUS's FCF Margin % is ranked better than 54.78% of 1046
companies
in the Biotechnology industry
Industry Median: -145.305
vs RCUS: -99.16
Arcus Biosciences FCF Margin % Historical Data
The historical data trend for Arcus Biosciences's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Arcus Biosciences's FCF Margin %
For the Biotechnology subindustry, Arcus Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcus Biosciences's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Arcus Biosciences's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Arcus Biosciences's FCF Margin % falls into.
Arcus Biosciences FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Arcus Biosciences's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcus Biosciences FCF Margin % Related Terms
Thank you for viewing the detailed overview of Arcus Biosciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Arcus Biosciences (Arcus Biosciences) Business Description
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RCUS has been successfully added to your 